Protein chip for detecting autoimmune antibodies of diabetes, preparation and detection method thereof

Through the combined structure of the titration plate and slide, combined with fluorescent antibiotic staining and digital signal processing technology, the problem of protein chip in activity and specificity maintenance is solved, and the analysis of high sensitivity and dynamic range is achieved. It is suitable for Detection and diagnosis of diabetic autoimmune antibodies.

CN113834932BActive Publication Date: 2024-11-15SHENZHEN SCIARRAY BIOTECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111147467.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-09-29
Publication Date
2024-11-15
Estimated Expiration
2041-09-29

AI Technical Summary

Technical Problem

The prior art is difficult to maintain protein activity and specificity when developing protein chips, and it is difficult to achieve high sensitivity and dynamic range analysis, especially in the detection of self-antigens, with problems of construction and standardization.

Method used

Using a combined structure of titration plate and slide, the antibody array is formed through fluorescent antibiotic staining and digital signal processing technology, the detection conditions are optimized by Lg(34) orthogonal method, and the fluorescence intensity is analyzed in combination with ScanArray4000 laser copolymerization scanner and QuantArray software to achieve Efficient fixation and detection of proteins and antibodies.

Benefits of technology

Achieving simultaneous detection of a variety of proteins and antibodies, improving the accuracy and cost-effectiveness of the detection, effectively typing patients with diabetes, and providing prediction basis in the early and early stages, with stable quality control and high purity antigens, reducing fluctuations in the detection results.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to the technical field of protein chips, and discloses a protein chip for detecting autoimmune antibodies of diabetes, comprising a titration plate, a filter membrane and a glass slide, wherein the filter membrane is placed on the titration plate, and proteins are dripped on the filter membrane, the glass slide is placed on the filter membrane and the glass slide and the titration plate are fitted to form an antibody array, the chip contains reaction sites defined for various analyses, and through the ligands in the soluble phase, the flat chip can simultaneously detect several immobilized proteins in a mixture composed of proteins, metabolites and other molecules, and the use of a multiplex assay method will generate redundant information. The most valuable function of the autoantibody chip is that it can generate a spectrum of autoantibodies. By analyzing the results of the multiplex chip with the help of computer spectrum recognition software, differential diagnosis of the disease can be performed, which can not only improve the accuracy of the diagnosis, but also improve the throughput and cost-effectiveness of the analysis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of protein chips, in particular to a protein chip for detecting autoimmune antibodies of diabetes, and a preparation method and a detection method thereof. Background Art

[0002] Protein chip is a high-throughput monitoring system that monitors the interaction between protein molecules through the interaction between target molecules and capture molecules. Capture molecules are generally pre-fixed on the chip surface. Due to the high specificity of antibodies and their strong binding properties with antigens, they are widely used as capture molecules. For the study of protein chips, it is very important to effectively fix antibodies on the chip surface, especially in terms of the consistency of fixed antibodies, which is very important for enhancing the sensitivity of protein chips. G protein is an antibody binding protein that specifically binds to the antibody FC fragment, so it has been widely used to fix different types of antibodies.

[0003] Compared with nucleic acid chips, protein chips are more difficult to develop. This is because proteins vary greatly in molecular size, charge, shape, hydrophobicity, type and degree of post-translational formation, and quaternary structure, and some proteins are difficult to maintain specificity and activity after being attached to a solid phase carrier. Simultaneous detection of autoantigens, as with various immunoassay methods, requires reasonably set, reproducible, and adjustable quantitative antigens. There are some problems in using chip technology for autoantigen determination, including how to obtain functional protein expression required for chip construction, developing technologies to attach proteins to the carrier surface and maintain their activity, and obtaining high analytical sensitivity and large dynamic range through chemistry and detection systems at the same time. So are assay standardization, data interpretation, and storage. Summary of the invention

[0004] 1. Technical issues to be solved

[0005] In view of the deficiencies of the prior art, the present invention provides a diabetic autoimmune antibody detection protein chip, and a preparation and detection method thereof.

[0006] (II) Technical solution

[0007] To achieve the above object, the present invention provides the following technical solution: a protein chip for detecting autoimmune antibodies of diabetes, comprising a titration plate, a filter membrane and a glass slide, characterized in that: the filter membrane is placed on the titration plate, and the protein is dripped on the filter membrane, the glass slide is placed on the filter membrane, and the glass slide and the titration plate are attached to form an antibody array;

[0008] The antibody array was stained with fluorescent antimicrobial bodies and encoded with fluorescent patterns.

[0009] Preferably, the protein chip classifies each antibody array according to a pre-set distribution area through digital signal processing technology, and various proteins in each antibody array are fixed in order on various media carriers such as glass slides to form a detection chip.

[0010] Preferably, the fluorescence intensity of each array on the chip analyzes the relationship between protein-protein interactions to achieve the purpose of determining various gene expression functions.

[0011] Preferably, the titration plate and the glass slide have specifications of 18 mm×60 mm and a thickness of 2 mm to 3 mm, and the reaction pools are all squares with a side length of 0.2 mm to 18 mm.

[0012] Preferably, the first step: antigen selection and preparation: preparing nuclear antigens and proteins by oneself;

[0013] Step 2: Selection and preparation of glass slides and selection of sample solution: prepare five glass slides with different fluorescence modifications;

[0014] Step 3: Protein chip preparation and optimization of detection conditions were performed using the Lg(34) orthogonal method, ScanArray4000 laser confocal scanner imaging, and QuantArray software to analyze fluorescence intensity. Based on the results, the best conditions were screened.

[0015] Step 4: Different probe molecules are fixed on the antibody array to form an antibody array protein chip system;

[0016] Step 5: react the probe-labeled antibody array with the sample;

[0017] Step 6: Detection of reaction results.

[0018] Preferably, the chip repeatability and stability experiment prepares a chip that can simultaneously detect 7 autoantibodies based on the above results, and tests the repeatability and stability of the chip, including the following testing steps:

[0019] 1) Dilute the serum to be tested 1:2 and hybridize it with the chip in a hybridization box at 37 degrees Celsius for 15 minutes, and seal it with a sealant at 37 degrees Celsius for 15 minutes;

[0020] 2) Wash with PBS three times, 15 seconds each time;

[0021] 3) Add 33 μg / ml Cy3-labeled goat anti-human IgG and incubate in the hybridization box for 30 min;

[0022] 4) Wash three times, each time for 15 seconds, and scan after drying. The entire experiment takes 1 hour to complete.

[0023] Preferably, the peptides in the antigen are derived from heat shock proteins, tissue antigens, immune system components, structural antigens, hormones, enzymes, plasma proteins, synthetic oligonucleotides and bacterial antigens.

[0024] (III) Beneficial effects

[0025] Compared with the prior art, the present invention provides a diabetic autoimmune antibody detection protein chip, its preparation and detection method, which has the following beneficial effects:

[0026] 1. The protein chip for detecting autoimmune antibodies of diabetes, its preparation and detection method. The technology uses a two-dimensional microchip, which contains reaction sites defined for various analyses. Through the ligands in the soluble stage, the flat chip can simultaneously detect several immobilized proteins in a mixture of proteins, metabolites and other molecules.

[0027] 2. The diabetes autoimmune antibody detection protein chip, its preparation and detection method, each array antibody device is processed individually in the best way, and then different array antibody devices are combined to prepare the final multiplexed array antibody reagent. A large number of analytes can be accommodated in the chip detection, so multiple internal controls can be used to ensure the expected performance of the measurement system. All measurement signals are standardized using fluorescent internal standards. This standardization compensates for fluctuations in the lighting and detection systems, and other internal tests in the autoimmune assay can also be designed according to the corresponding clinical specimen type and sample volume.

[0028] 3. The diabetes autoimmune antibody detection protein chip, its preparation and detection method, uses a multiplexed assay method to generate redundant information. The most valuable function of the autoantibody chip is that it can generate a spectrum of autoantibodies. By analyzing the results of the multiplexed chip with the help of computer spectrum recognition software, differential diagnosis of the disease can be performed, which can not only improve the accuracy of diagnosis, but also improve the throughput and cost-effectiveness of the analysis.

[0029] 4. The diabetes autoimmune antibody detection protein chip, its preparation and detection method can provide an important basis for the typing and identification of patients with immune-mediated diabetes by determining the presence or content of diabetes autoimmune antibodies in serum. It can also be widely used in the prediction of the preclinical and early stages of type 1 diabetes in high-risk populations for diabetes, and therefore has important clinical practical value.

[0030] 5. The diabetes autoimmune antibody detection protein chip, its preparation and detection method, and stable quality control. The highly purified antigen protein ensures the stability of the antigen quality, reduces the batch-to-batch differences, and thus effectively realizes the detection standardization and reduces the fluctuation of the test results. At the same time, each chip has an independent quality control detection microarray to ensure the reliability of the quality of each chip. DETAILED DESCRIPTION

[0031] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0032] The invention discloses a protein chip for detecting autoimmune antibodies of diabetes, comprising a titration plate, a filter membrane and a glass slide, wherein the filter membrane is placed on the titration plate and proteins are dripped onto the filter membrane, the glass slide is placed on the filter membrane and the glass slide and the titration plate are attached to form an antibody array; the antibody array is stained by fluorescent antibiotics and the antibody array is encoded by fluorescent patterns, the protein chip classifies each antibody array according to a pre-set distribution area by digital signal processing technology, various proteins in each antibody array are fixed in order on various medium carriers such as glass slides to become a detection chip, the fluorescence intensity of each array on the chip analyzes the relationship between the interaction between proteins, so as to achieve the purpose of determining various gene expression functions, the titration plate and the glass slide have specifications of 18mm×60mm and thickness of 2mm-3mm, and the reaction pools are all squares with side lengths of 0.2mm-18mm.

[0033] The preparation method of the protein chip for detecting autoimmune antibodies in diabetes, the first step: antigen selection and preparation: self-preparation of nuclear antigens and proteins. According to the needs of current clinical testing, antigens for seven autoantibodies were selected, namely ANA, dsDNA, Ro-60 / SSA, Ro52 / SSA, La / SSB, Jo-1, and cardiolipin. Nuclear proteins were extracted from human laryngeal cancer epithelial cells as nuclear antigens, and their protein concentrations were measured. Plasmid DNA was extracted from the prokaryotic expression vector pcDNAII as an antigen for detecting anti-dsDNA antibodies. It was verified by agarose electrophoresis that it did not contain ssDNA. The self-prepared antigens can meet the requirements for antibody detection.

[0034] Step 2: Selection and preparation of glass slides and selection of sample solution: Five different fluorescent modified glass slides were prepared respectively. The APES modified glass slide selected as a solid phase substrate can not only fix proteins but also nucleic acids and lipids at the same time, which is very suitable for the characteristics of diversified antigen fixation of autoimmune disease antibody detection chip; the selected PBST as the spotting solution can not only fix antigens well, but also improve the sensitivity of detection, and the minimum detection amount can reach 50pg. The spotting solution for cardiolipin is DMSO.

[0035] Step 3: Optimization of protein chip preparation and detection conditions. The Lg (34) orthogonal method, ScanArray 4000 laser co-polymerization scanner imaging, and QuantArray software analysis of fluorescence intensity were used. Based on the results, the optimal conditions were screened. The optimized conditions for protein chip preparation and detection screened out through orthogonal design experiments were: incubation in a hybridization box at 37 degrees Celsius for 2 hours after spotting; washing with PBS; blocking with PBST containing 1% BSA and 2.5% sucrose for 30 minutes; reacting with secondary antibody for 30 minutes. The secondary antibody and serum reaction conditions screened out through orthogonal design experiments were: serum dilution 1:2; Cy3-labeled goat anti-human IgG concentration of 33 pug / ml; serum reaction time of 15 minutes.

[0036] Step 4: Different probe molecules are fixed on the antibody array to form an antibody array protein chip system. The array antibody matrix with labeled probes is reacted with the sample. The probes can specifically bind to the corresponding target molecules, and the reporter molecules with green reporter fluorescence also specifically bind to the target molecules to quantify the reaction.

[0037] Step 5: react the probe-labeled antibody array with the sample;

[0038] Step 6: Detection of reaction results.

[0039] Repeatability and stability test of the chip Based on the above results, a chip that can simultaneously detect 7 autoantibodies was prepared, and the repeatability and stability of the chip were tested, including the following test steps:

[0040] 1) Dilute the serum to be tested in the manner of 1:2, 1:3, 1:4 and 1:5 and hybridize it with the chip in a 37 degree Celsius hybridization box for 15 minutes, and seal it with a sealant at 37 degrees Celsius for 15 minutes to form four different concentrations of test solution, and select two specific reaction pools. The chip is equipped with two additional quality control reaction pools to test the quality of the chip. The result judgment standard is: if the ratio of the average fluorescence intensity of the protein spot on each test chip of the positive quality control test microarray to the background fluorescence intensity is higher than 50:1, and the ratio of the average fluorescence intensity of the protein spot on each test chip of the negative quality control test microarray to the background fluorescence intensity is lower than 50:1, it indicates that the chip is of good quality and the test result is valid;

[0041] 2) Wash with PBS three times, 15 seconds each time;

[0042] 3) Add 33 μg / ml Cy3-labeled goat anti-human IgG and incubate in the hybridization box for 30 min;

[0043] 4) Wash three times, each time for 15 seconds, and scan after drying. The entire experiment takes 1 hour to complete.

[0044] The peptides in the antigens come from heat shock proteins, tissue antigens, immune system components, structural antigens, hormones, enzymes, plasma proteins, synthetic oligonucleotides and bacterial antigens. The antigen concentration and serum dilution results are: nuclear antigen, 300ug / ml; dsDNA, 200ug / ml; Ro-60 / SSA, 100ug / ml; Ro-52 / SSA, 2004g / ml; La / SSB, 300ug / ml; Jo-1, 200ug / ml; cardiolipin, 2000μg / ml; serum dilution 1:2.

[0045] By comparing the spotting solution and serum dilution, the serum dilution with the highest signal-to-noise ratio is 1:2. The TBST containing 0.1% Tween20 selected as the spotting solution can not only fix the antigen well, but also improve the sensitivity of detection. The concentration-gray value linear relationship of the protein chip Human IgG and 12 antigens (the spotting solution is TBST containing 0.1% Tween20, and the serum dilution is 1:2) is greater than 0.97, and the linear relationship is good, indicating that the protein chip can perform qualitative and semi-quantitative detection of corresponding antibodies in serum within the antigen concentration range we selected.

[0046] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A protein chip for detecting autoimmune antibodies of diabetes, comprising a titration plate, a filter membrane and a glass slide, characterized in that: The filter membrane is placed on a titration plate, and the protein is dropped onto the filter membrane, a glass slide is placed on the filter membrane, and the glass slide and the titration plate are attached to form an antibody array; The antibody array was stained with fluorescent antimicrobial bodies and encoded with fluorescent patterns.

2. The diabetic autoimmune antibody detection protein chip according to claim 1, characterized in that: The protein chip classifies each antibody array according to a pre-set distribution area through digital signal processing technology, and various proteins in each antibody array are fixed in order on various medium carriers on a glass slide to form a detection chip.

3. The diabetic autoimmune antibody detection protein chip according to claim 1, characterized in that: The titration plate and the glass slide have specifications of 18 mm×60 mm and thickness of 2 mm to 3 mm, and the reaction pools are all squares with side lengths of 0.2 mm to 18 mm.